Martínez M T, Pérez F, Calvillán M, Gutierrez-López M D, Serrano-Ríos M
Unidad de Lípidos y Diabetes, Hospital Clínico San Carlos, Universidad Complutense, Madrid, España.
Rev Med Chil. 1994 Oct;122(10):1115-9.
To study serum Lp(a) levels and other metabolic cardiovascular risk factors in children with type I diabetes mellitus (DM) in comparison with sex and age matched nondiabetic children. To determine the influence of diabetes control on serum lipoprotein (a) concentrations.
Transversal observational study.
diabetic group: 70 type I DM children without microalbuminuria and no macro-microvascular nor neurological complications, aged from 8 to 15 years; 30 boys, 40 girls. Mean duration of type I DM was 8 +/- 4 years. Non diabetic group: composed by 123 healthy children with no family history of DM, aged from 8 to 15 years, 53 boys, 70 girls.
The lipids profile include: total cholesterol (TC) and triglyceride (TG), cholesterol high-density lipoproteins (C-HDL) cholesterol very-low-density lipoproteins (C-LDL) and cholesterol low-density lipoproteins (C-LDL). ApoAI, APOAII and ApoB, Lp(a) and fructosamine.
Fructosamine concentration in diabetic children was 340 +/- 108 uM/1 in 240 +/- 25 uM/l nondiabetic children. Lp(a) serum levels did not significantly differ among both groups 17 +/- 16 mg/dl in diabetics 19 +/- 18 mg/dl in controls. Multivariate analysis showed that in the diabetic children the worsening of metabolic control as reflected by fructosamine, was positively correlated with the increase in total Lp(a) serum concentration.
In children aged 8-15 years with uncomplicated IDDM lasting less than 15 years duration, Lp(a) serum levels are positively correlated with the poorest metabolic control.
研究1型糖尿病(DM)患儿的血清脂蛋白(a)[Lp(a)]水平及其他代谢性心血管危险因素,并与性别和年龄匹配的非糖尿病儿童进行比较。确定糖尿病控制情况对血清脂蛋白(a)浓度的影响。
横向观察性研究。
糖尿病组:70例无微量白蛋白尿、无大微血管及神经并发症的1型糖尿病患儿,年龄8至15岁;30名男孩,40名女孩。1型糖尿病的平均病程为8±4年。非糖尿病组:由123名无糖尿病家族史的健康儿童组成,年龄8至15岁,53名男孩,70名女孩。
血脂谱包括:总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(C-HDL)、极低密度脂蛋白胆固醇(C-VLDL)和低密度脂蛋白胆固醇(C-LDL)。载脂蛋白AI(ApoAI)、载脂蛋白AII(APOAII)、载脂蛋白B(ApoB)、Lp(a)和果糖胺。
糖尿病患儿的果糖胺浓度为340±108μM/L,非糖尿病儿童为240±25μM/L。两组的Lp(a)血清水平无显著差异,糖尿病组为17±16mg/dl,对照组为19±18mg/dl。多变量分析显示,在糖尿病患儿中,果糖胺反映的代谢控制恶化与血清总Lp(a)浓度增加呈正相关。
在病程小于15年、无并发症的8至15岁1型糖尿病患儿中,Lp(a)血清水平与最差的代谢控制呈正相关。